These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
209 related items for PubMed ID: 30085003
1. The characteristics of Clostridium difficile ST81, a new PCR ribotype of toxin A- B+ strain with high-level fluoroquinolones resistance and higher sporulation ability than ST37/PCR ribotype 017. Wang B, Peng W, Zhang P, Su J. FEMS Microbiol Lett; 2018 Sep 01; 365(17):. PubMed ID: 30085003 [Abstract] [Full Text] [Related]
2. High-level resistance to moxifloxacin and gatifloxacin associated with a novel mutation in gyrB in toxin-A-negative, toxin-B-positive Clostridium difficile. Drudy D, Quinn T, O'Mahony R, Kyne L, O'Gaora P, Fanning S. J Antimicrob Chemother; 2006 Dec 01; 58(6):1264-7. PubMed ID: 17018563 [Abstract] [Full Text] [Related]
3. The tcdA-negative and tcdB-positive Clostridium difficile ST81 clone exhibits a high level of resistance to fluoroquinolones: a multi-centre study in Beijing, China. Cheng JW, Liu C, Kudinha T, Xiao M, Fan X, Yang CX, Wei M, Liang GW, Shao DH, Xiong ZJ, Hou X, Yu SY, Wang Y, Yang QW, Su JR, Xu YC. Int J Antimicrob Agents; 2020 Jul 01; 56(1):105981. PubMed ID: 32330584 [Abstract] [Full Text] [Related]
4. Two Clusters of Fluoroquinolone and Clindamycin-Resistant Clostridium difficile PCR Ribotype 001 Strain Recognized by Capillary Electrophoresis Ribotyping and Multilocus Variable Tandem Repeat Analysis. Nyc O, Tejkalova R, Kriz Z, Ruzicka F, Kubicek L, Matejkova J, Kuijper E, Krutova M. Microb Drug Resist; 2017 Jul 01; 23(5):609-615. PubMed ID: 27860531 [Abstract] [Full Text] [Related]
5. Fluoroquinolone resistance in Clostridium difficile isolates from a prospective study of C. difficile infections in Europe. Spigaglia P, Barbanti F, Mastrantonio P, Brazier JS, Barbut F, Delmée M, Kuijper E, R Poxton I, On Behalf Of The European Study Group On Esgcd. J Med Microbiol; 2008 Jun 01; 57(Pt 6):784-789. PubMed ID: 18480338 [Abstract] [Full Text] [Related]
6. The recognition and characterisation of Finnish Clostridium difficile isolates resembling PCR-ribotype 027. Krutova M, Nyc O, Matejkova J, Kuijper EJ, Jalava J, Mentula S. J Microbiol Immunol Infect; 2018 Jun 01; 51(3):344-351. PubMed ID: 28583353 [Abstract] [Full Text] [Related]
7. Epidemiology of Clostridium difficile infection in hospitalized adults and the first isolation of C. difficile PCR ribotype 027 in central China. Zhou Y, Mao L, Yu J, Lin Q, Luo Y, Zhu X, Sun Z. BMC Infect Dis; 2019 Mar 07; 19(1):232. PubMed ID: 30845918 [Abstract] [Full Text] [Related]
8. The changes of PCR ribotype and antimicrobial resistance of Clostridium difficile in a tertiary care hospital over 10 years. Lee JH, Lee Y, Lee K, Riley TV, Kim H. J Med Microbiol; 2014 Jun 07; 63(Pt 6):819-823. PubMed ID: 24696516 [Abstract] [Full Text] [Related]
9. Clostridium difficile isolates resistant to fluoroquinolones in Italy: emergence of PCR ribotype 018. Spigaglia P, Barbanti F, Dionisi AM, Mastrantonio P. J Clin Microbiol; 2010 Aug 07; 48(8):2892-6. PubMed ID: 20554809 [Abstract] [Full Text] [Related]
10. Clostridium difficile infection among immunocompromised patients in Rio de Janeiro, Brazil and detection of moxifloxacin resistance in a ribotype 014 strain. Secco DA, Balassiano IT, Boente RF, Miranda KR, Brazier J, Hall V, dos Santos-Filho J, Lobo LA, Nouér SA, Domingues RM. Anaerobe; 2014 Aug 07; 28():85-9. PubMed ID: 24907488 [Abstract] [Full Text] [Related]
11. Molecular characterization of moxifloxacin resistance from Canadian Clostridium difficile clinical isolates. Walkty A, Boyd DA, Gravel D, Hutchinson J, McGeer A, Moore D, Simor A, Suh K, Taylor G, Miller M, Mulvey MR, Canadian Nosocomial Infection Surveillance Program. Diagn Microbiol Infect Dis; 2010 Apr 07; 66(4):419-24. PubMed ID: 20226332 [Abstract] [Full Text] [Related]
13. A nationwide study of molecular epidemiology and antimicrobial susceptibility of Clostridioides difficile in South Korea. Byun JH, Kim H, Kim JL, Kim D, Jeong SH, Shin JH, Kim YA, Shin JH, Shin KS, Uh Y. Anaerobe; 2019 Dec 07; 60():102106. PubMed ID: 31655214 [Abstract] [Full Text] [Related]
16. Phenotypic characterisation of Clostridium difficile PCR ribotype 251, an emerging multi-locus sequence type clade 2 strain in Australia. Hong S, Knight DR, Chang B, Carman RJ, Riley TV. Anaerobe; 2019 Dec 07; 60():102066. PubMed ID: 31260740 [Abstract] [Full Text] [Related]
17. Occurrence of Clostridium difficile PCR-ribotype 027 and it's closely related PCR-ribotype 176 in hospitals in Poland in 2008-2010. Obuch-Woszczatyński P, Lachowicz D, Schneider A, Mól A, Pawłowska J, Ożdżeńska-Milke E, Pruszczyk P, Wultańska D, Młynarczyk G, Harmanus C, Kuijper EJ, van Belkum A, Pituch H. Anaerobe; 2014 Aug 07; 28():13-7. PubMed ID: 24799338 [Abstract] [Full Text] [Related]
18. Toxin A-negative toxin B-positive ribotype 017 Clostridium difficile is the dominant strain type in patients with diarrhoea attending tuberculosis hospitals in Cape Town, South Africa. Kullin B, Wojno J, Abratt V, Reid SJ. Eur J Clin Microbiol Infect Dis; 2017 Jan 07; 36(1):163-175. PubMed ID: 27696234 [Abstract] [Full Text] [Related]
19. Antimicrobial susceptibility patterns of Clostridium difficile strains belonging to different polymerase chain reaction ribotypes isolated in Poland in 2012. Lachowicz D, Pituch H, Obuch-Woszczatyński P. Anaerobe; 2015 Feb 07; 31():37-41. PubMed ID: 25242196 [Abstract] [Full Text] [Related]
20. Antimicrobial susceptibility and molecular typing of toxigenic clinical isolates of Clostridium difficile causing infections in the south of Spain. Arca-Suárez J, Galán-Sánchez F, Cano-Cano F, García-Santos G, Rodríguez-Iglesias MA. Anaerobe; 2018 Dec 07; 54():146-150. PubMed ID: 30261271 [Abstract] [Full Text] [Related] Page: [Next] [New Search]